Evolution Equity Partners Announces Final Close of New Cybersecurity Focused Fund
17.7.2017 16:00 | Business Wire
Evolution Equity Partners today announced the final closing of a new fund with total capital commitments of $125 million to make investments in cybersecurity and next generation enterprise software and services in North America, Europe and Israel. The fund exceeded its target and is backed by leading institutional investors, corporates, family offices and technology entrepreneurs from the United States and Europe including Cisco Investments, The European Investment Fund (EIF), Witelo Fund (PZU Insurance Group), Alpha Associates among others.
The Evolution Technology Fund L.P. will make investments in the range of $5 million to $25 million in early and growth stage companies in cybersecurity and in companies utilizing machine learning, big data, SaaS, mobile and the convergence of consumer and enterprise software to build market leading platforms. Evolution sees tremendous opportunity in Europe, the United States and Israel alike to partner and invest in next generation cybersecurity and enterprise software companies and help position them for international growth.
Evolution Equity Partners was founded by investor and technology entrepreneurs Richard Seewald and Dennis Smith, who manage and lead the firm, and are joined by partners Karel Obluk (former CTO, AVG Technologies), J.R. Smith (former CEO, AVG Technologies), and a specialist team of professionals. The team members have been founders, operating executives and investors in leading software companies around the world and are committed to a mission of helping exceptional entrepreneurs develop market leading companies. Current and past portfolio companies include category leaders: AVG Technologies, OpenDNS, Carbon Black, Cognitive Security, Security Scorecard, Onapsis, Fortscale, LogPoint, DFLabs, Eperi and Panaseer among others.
“Evolution’s sector focus, along with the partners’ deep operating, technical and product development expertise allows us to take a concentrated approach in identifying leading entrepreneurial companies poised for growth,” said managing partner Richard Seewald. “We see tremendous opportunity in Europe, North America and Israel alike where management teams of rapidly growing software companies seek investors that can help with international expansion. Evolution has considerable experience in developing and exploiting new markets internationally and has become a preferred partner for cybersecurity and enterprise software entrepreneurs. The closing of the Evolution Technology Fund L.P. demonstrates the commitment of our global investors to our strategy and approach.”
“We are in the early innings of a secular trend in the cybersecurity space that involves increased spend by large enterprises, smaller businesses and consumers alike, an expanding threat landscape, market consolidation and demand for next generation products and services that makes this a very compelling segment for investment,” said managing partner Dennis Smith. “Likewise the enterprise software and services segment is experiencing unprecedented disruptive forces – cloud, mobile, hyper connectivity - that position next generation companies well while creating attractive investment opportunity.”
About Evolution Equity Partners
Evolution Equity Partners, based in New York City and Zurich, Switzerland, invests in fast growing technology companies helping exceptional entrepreneurs develop market leading companies. The firm has a focus on Cybersecurity and Enterprise Software and its partners have been founders, investors and senior operating executives in leading software companies around the world. Evolution was founded by investor and technology entrepreneurs Richard Seewald and Dennis Smith, who manage the firm, and are joined by partners Karel Obluk (former CTO of AVG Technologies) and J.R. Smith (former CEO of AVG Technologies) to lead a specialist team of professionals. Current and past portfolio companies include: AVG Technologies (NYSE: AVG), Cognitive Security, OpenDNS, Carbon Black, Onapsis, Security Scorecard, DFLabs, Fortscale, LogPoint, Eperi, Panaseer among others. For more information, please visit us at evolutionequity.com or connect with us on Twitter @evolutionequity.
Leslie Kesselring, 503-358-1012
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme tältä julkaisijalta, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
Major Terrorist Plot Foiled in Saudi Arabia, Ministry of Interior Announces21.7.2017 21:33 | Tiedote
The following is a statement from Saudi Arabia’s Ministry of Culture and Information: This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170721005575/en/ Weapons and other items found in the possession of the three terrorists are an indication of the ugliness and severity of the acts of terrorism they were planning to carry out, victimizing innocent lives and private and public property. (Photo: ME NewsWire) The Saudi Ministry of Interior has announced that a major terrorist attack was prevented by security services in the city of Saihat in the Qatif governorate. On the evening of Friday, July 14th, security services intercepted a stolen Toyota Corolla vehicle in a busy, built-up district of the city. As the stolen vehicle was surrounded by security services, three men in the ca
Janssen Receives Positive CHMP Opinion for SYMTUZA™ The First Darunavir-Based Single-Tablet Regimen for the Treatment of HIV21.7.2017 15:09 | Tiedote
Janssen-Cilag International NV (Janssen) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a Positive Opinion recommending marketing authorisation for SYMTUZA™ (darunavir/cobicistat/emtricitabine/tenofovir alafenamide [D/C/F/TAF]), a once-daily darunavir-based single tablet regimen (STR). If approved, it will be the only darunavir-based STR indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and adolescents aged 12 years and older with body weight of at least 40 kg, with genotypic testing guiding use. This STR combines the proven efficacy and durability of darunavir with the improved renal laboratory and bone mineral density profile of F/TAF as compared to F/TDF (tenofovir disoproxil fumarate), and will be the only treatment that could deliver the adherence advantag
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (Telotristat Ethyl), for the Treatment of Carcinoid Syndrome Diarrhea in Patients Inadequately Controlled by Somatostatin Analogue Therapy21.7.2017 14:26 | Tiedote
Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA), has adopted a positive opinion recommending the approval of Xermelo® (telotristat ethyl) 250 mg three times a day (tid) for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analogue (SSA) therapy in adults inadequately controlled by SSA therapy. The CHMP positive opinion will now be reviewed by the European Commission (EC), which has the authority to approve medicines for use in the 28 countries of the European Union, as well as Norway, Liechtenstein and Iceland. David Meek, Chief Executive Officer of Ipsen, said: “The positive CHMP opinion for Xermelo ® is an important milestone towards providing innovative s
Schlumberger Announces Second-Quarter 2017 Results21.7.2017 14:00 | Tiedote
Schlumberger Limited (NYSE:SLB) today reported results for the second quarter of 2017. (Stated in millions, except per share amounts) Three Months Ended Change Jun. 30, 2017 Mar. 31, 2017 Jun. 30, 2016
NRI Secure Launches Japan's First "Blockchain Assessment" Service21.7.2017 10:00 | Tiedote
NRI SecureTechnologies, Ltd. (President: Jun Odashima; hereinafter NRI Secure), a leading provider of information security solutions in Japan, has begun providing Japan’s first-ever*1 “Blockchain Assessment,” a security Assessment service designed for systems and services which use blockchain technology*2. This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170721005012/en/ Overview of the "Blockchain Assessment" Service (Graphic: Business Wire) As the blockchain technology has become more widespread, the presence of security-related vulnerabilities has also become increasingly apparent. In particular, with regard to smart contracts, *3 one of a constituent element of services using the blockchain, a cyberattack carried out on any vulnerable programs could lead to major threats or eve
Business Figures for the First Half of 2017: Sartorius Continues to Grow21.7.2017 08:00 | Tiedote
Sartorius (FWB:SRT), a leading international laboratory and pharmaceutical equipment supplier, continues on the growth track. In the first half of 2017, solid organic business development and two acquisitions led to a significant increase in sales revenue and earnings1. "Sartorius has continued its dynamic, profitable development," said CEO and Executive Board Chairman Dr. Joachim Kreuzburg in commenting on the company's first-half performance. "Both divisions achieved solid organic growth in an environment that was especially challenging in North America, and have made quick progress in integrating the businesses most recently acquired. In the Lab Products & Services Division, the bioanalytics unit newly created by our acquisitions has already contributed significant revenues and earnings. We see further considerable growth potential ahead for this business just as for the
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme